Pear Therapeutics Files for Chapter 11, Seeks Sale

Pear Therapeutics says it made a voluntary Chapter 11 bankruptcy filing in Delaware.

• Will pursue sale of the business or assets
• Plans to continue scaled-down operations during Chapter 11 process
• According to the bankruptcy filing:
  • Estimated liabilities: $10,000-$50 million
  • Estimated assets: $10,000-$50 million
• NOTE: March 17, Pear Plummets After Pulling Guidance, Opening Strategic Review

To view the source of this information, click here

To contact the reporters on this story:
Jim Silver in New York at jsilver@bloomberg.net;
Shiyin Chen in Los Angeles at schen37@bloomberg.net

To contact the editor responsible for this story:
Max Zimmerman at mzimmerman90@bloomberg.net

© 2023 Bloomberg ...